IDEX IDEX Biometrics ASA

IDEX Biometrics – Interim report for the fourth quarter and preliminary result of 2020

IDEX Biometrics – Interim report for the fourth quarter and preliminary result of 2020

The report and an updated company presentation are enclosed in pdf files.

Fourth Quarter and Preliminary Full Year Financial Results

o            Fourth quarter 2020 revenue was $598 thousand compared to $71 thousand in the fourth quarter 2019 as revenue begins to accelerate

o            Full year 2020 revenue was $1.1 million, including $1 million in product revenue, compared to $159 thousand in product revenue in 2019

o            Fourth quarter and full year gross margins(*) were 70% and 75%, respectively

o            2020 Adjusted Operating Expenses(**) were $21.4 million, a decrease of $4.9 million or 19% compared to $26.3 million in 2019

o            Net loss narrowed to $26.8 million in 2020 from $32.4 million in 2019

o            Ended the year with $7.3 million in cash and raised $26.1 million, net of fees, in a private placement on February 15, 2021 

o            IDEX was approved to list on the Nasdaq and expects to begin trading on March 1, 2021 under ticker IDBA

Commercial and Market Updates

o            After securing an initial order in the third quarter, IDEX received an additional production order for TrustedBio™ sensors from a tier 1 card manufacturer in late 2020 that will be incorporated in a card available to financial institutions early 2021

o            Achieved an additional China UnionPay (CUP) certification for dual interface biometric payment cards with its partner Goldpac. This is the second certification with a card manufacturer on the CUP network

o            IDEX’s sensor was featured by our partner, CTD, in the first trial of a fingerprint card for a digital RMB hardware wallet in a trial by Postal Savings Bank of China.  The DCEP digital currency initiative in China represents a large market opportunity beyond the traditional payment card market. 

o            Continued to expand its strategic partnerships and added a third global payment network to deliver its fingerprint sensors and related biometric solutions

o            Received advanced volume production orders of TrustedBio sensors from multiple tier 1 card manufacturers to secure allocation of future supply

o            Expanded its direct customer engagements with tier 1 innovation leaders, representing over 40% share of the global payment card market

o            Continued to ramp production shipments to a large IT and financial services customer for an information security access control solution

Vince Graziani, CEO of IDEX, commented: “During 2020 we made good progress transitioning from pure product development to commercial activities and ramping of deliveries.  Throughout the year we achieved several certifications by multiple major payment networks. Several new card manufacturers have initiated new product developments based on IDEX’s biometric technologies.  In addition to ramping commercial production shipments for a large IT and financial services customer, we successfully secured the first commercial orders and began shipment of our next-generation TrustedBio™ solution for biometric payment cards.”

He added: “Entering the new year, the Postal Savings Bank of China announced the first trial of a fingerprint biometric card hardware-wallet as part of China’s digital renminbi (RMB) initiative.   This initiative represents a new high-volume application for fingerprint biometrics.  We expect 2021 will see broader use of our technology for these new digital currency applications globally, and increasing orders and shipments to a broader range of traditional customers, banks and credit issuers.”

Notes:

* Gross Margin is Total Revenue less Purchases, net of inventory change

** Adjusted Operating Expense is Total Operating Expenses less stock compensation expense, amortization and depreciation expense, and expense related to the Nasdaq listing

For further information contact:

Marianne Bøe, Investor Relations

E-mail:

Tel:

Derek D’Antilio, Chief Financial Officer

E-mail:

Tel: +1 978 273 1344

About IDEX Biometrics

IDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of fingerprint identification technologies offering simple, secure and personal authentication for all.  We help people make payments, prove their identity, gain access to information, unlock devices or gain admittance to buildings with the touch of a finger. We invent, engineer, and commercialize these secure, yet incredibly user-friendly solutions.  Our total addressable market represents a fast growing multi-billion-unit opportunity.

For more information, visit and follow on Twitter @IDEXBiometrics

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Attachments



EN
25/02/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IDEX Biometrics ASA

 PRESS RELEASE

IDEX Biometrics ASA – EX. SHARE CONSOLIDATION (REVERSE SPLIT) TODAY - ...

IDEX Biometrics ASA – EX. SHARE CONSOLIDATION (REVERSE SPLIT) TODAY - 9 Jan 2024 Issuer name: IDEX Biometrics ASA Ex. date: 9 January 2024 Type of corporate action: Share consolidation (reverse split) Previous ISIN: NO0003070609 New ISIN: NO0013107490 For further information contact:Marianne Bøe, Investor RelationsE-mail: Tel: About this noticeThis notice was published by Erling Svela, Vice president of finance, on 9 January 2024 at 08:00 CET on behalf of IDEX Biometrics ASA. The information shall be disclosed according to Continuing Obligations at Oslo Børs Euronext and is published ...

 PRESS RELEASE

IDEX Biometrics ASA – EX. AKSJESPLEIS I DAG – 9. januar 2024

IDEX Biometrics ASA – EX. AKSJESPLEIS I DAG – 9. januar 2024 Utstedernavn: Idex Biometrics ASA Ex. Dato: 9. januar 2024 Type selskapshandling: Aksjespleis Tidligere ISIN: NO0003070609 Ny ISIN: NO0013107490 For ytterligere informasjon kontact:Marianne Bøe, investorkontaktE-mail: Tel: Om denne meldingenDenne meldingen ble publisert av økonomisjef Erling Svela den 9. januar 2024 kl 08:00 CET på vegne av IDEX Biometrics ASA. Informasjonen skal offentligjøres iht løpende forpliktelser ved Oslo Børs Euronext og utsendes i tråd med paragraf 5‑12 i verdipapirhandelloven.

 PRESS RELEASE

Registration of share consolidation (reverse split) in IDEX Biometrics...

Registration of share consolidation (reverse split) in IDEX Biometrics - 8 Jan 2024 Reference is made to the notice on 21 December 2023 about the five-to-one share consolidation (reverse split) resolved by the extraordinary general meeting on the same day, agenda item 3. The consolidation has been registered. Following the registration, the company's share capital remains NOK 209,551,597.50, but is now divided into 279,402,130 shares, each with a nominal value of NOK 0.75. For the avoidance of doubt, the registration does not affect the dates set forth in the notice of key informatio...

 PRESS RELEASE

Registration of share capital increase in IDEX Biometrics 29 Dec 2023

Registration of share capital increase in IDEX Biometrics 29 Dec 2023 Reference is made to the notice on 22 December 2023 regarding issue of two shares  at NOK 0.15 per shareto an employee of the company as part of the five-to-one share consolidation resolved by the extraordinary general meeting on 21 December 2023, agenda item 3. The consolidation of shares will take place on or about 10 January 2024. Reference is made to the notice of the extraordinary general meeting issued on 30 November 2023 and the notice of resolutions made by the extraordinary general meeting issued on 21 December 2...

 PRESS RELEASE

IDEX Biometrics convertible loan agreement completed 28 Dec 2023

IDEX Biometrics convertible loan agreement completed 28 Dec 2023 Reference is made to the notice by IDEX Biometrics ASA on 26 December 2023 that the convertible loan agreement had been entered into. All closing conditions have now been met and satisfied and closing of the convertible bond transaction has been completed. The initial conversion price, NOK 0.7330 per share, was correctly stated in the notice, but the calculation basis should have been phrased as follows: “The initial conversion price will be NOK 0.7330 per share, which is 125% of the lowest volume weighted average price (VWAP...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch